AAA Valeritas medicates with $9.4m

Valeritas medicates with $9.4m

Valeritas, a US-based maker of the V-Go drug patch for diabetes, has raised $9.4m of a planned $10m round.

In a regulatory filing first seen by Citybizlist, Valeritas has 20 investors in the round so far.

Valeritas’ primary investors include US-based corporate venturing unit Kaiser Permanente Ventures, Agate Medical Investments, a $60m fund with the backing of Clal Insurance, and venture capital firms MPM Capital, Pitango Venture Capital, Abingworth, US Venture Partners, Onset Ventures, ATV Capital, HLM Venture Partners and CHL Medical Partners.

Leave a comment

Your email address will not be published. Required fields are marked *